TCL Archive First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma February 22, 2013
TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013